Covalon Technologies (NYSE: COV) and Landauer (NYSE:LDR) are both medical equipment, supplies & distribution – nec companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.
Valuation & Earnings
This table compares Covalon Technologies and Landauer’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
Covalon Technologies is trading at a lower price-to-earnings ratio than Landauer, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
79.6% of Landauer shares are held by institutional investors. 6.6% of Landauer shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This table compares Covalon Technologies and Landauer’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Covalon Technologies has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Landauer has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500.
This is a summary of recent ratings and price targets for Covalon Technologies and Landauer, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Landauer pays an annual dividend of $1.10 per share and has a dividend yield of 1.6%. Covalon Technologies does not pay a dividend. Landauer pays out 57.3% of its earnings in the form of a dividend. Landauer has increased its dividend for 8 consecutive years.
Landauer beats Covalon Technologies on 7 of the 10 factors compared between the two stocks.
Covalon Technologies Company Profile
Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company’s segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company’s products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.
Landauer Company Profile
Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company’s Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company’s Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.
Receive News & Ratings for Covalon Technologies Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies Ltd and related companies with MarketBeat.com's FREE daily email newsletter.